Metal-free Aerobic C-H Oxidation of Cyclic Enones · 2014-06-16 · 1 Metal-free Aerobic C-H...
Transcript of Metal-free Aerobic C-H Oxidation of Cyclic Enones · 2014-06-16 · 1 Metal-free Aerobic C-H...
1
Metal-free Aerobic C-H Oxidation of Cyclic Enones
P. A. Peixoto, M. Cormier, J. Ekosso Epane, A. Jean, J. Maddaluno, M. De Paolis
Table of contents
I) Experimental Section 2
II) Abbreviations 14
III) 1H and 13C NMR Spectra 15
Electronic Supplementary Material (ESI) for Organic Chemistry Frontiers.This journal is © the Partner Organisations 2014
2
I) Experimental Section
All reactions were carried out under a nitrogen or argon atmosphere with dry solvents
under anhydrous conditions, unless otherwise noted. Dry tetrahydrofuran (THF), diethyl ether
(Et2O), methylene chloride (CH2Cl2), and toluene were obtained by distillation (from CaH2
for CH2Cl2, sodium/benzophenone for THF, from sodium for toluene and, from sodium
benzophenone for Et2O). Methanol (MeOH), N,N'-dimethylformamide (DMF) and
dimethylsulfoxide (DMSO) were purchased in anhydrous form and used without further
purification. Ethyl acetate (EtOAc), diethyl ether (Et2O), methylene chloride (CH2Cl2), and
cyclohexane were purchased at ACS grade quality and used without further purification,
unless otherwise stated. Reagents were purchased at the highest commercial quality and used
without further purification, unless otherwise stated. Yields refer to chromatographically and
spectroscopically (1H NMR and 13C NMR) homogeneous materials, unless otherwise stated.
Reactions were monitored by thin-layer chromatography (TLC) carried out on Merck silica
gel plates with QF-254 indicator and an ethanolic solution of ammonium molybdate or
potassium permanganate and heat as developing agents. Merck silica gel (60, particle size
0.040-0.063 mm) was used for flash column chromatography. NMR spectra were recorded on
Bruker Advance DMX -300 or -200 instruments and calibrated using residual undeuterated
solvent as an internal reference (7.26 ppm and 77.00 ppm for 1H and 13C NMR in CDCl3; 7.16
ppm and 128.06 ppm for 1H and 13C NMR in C6D6). The following abbreviations were used
to describe the multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, quint = quintet,
m = multiplet, pent = pentet, hex = hexet, br = broad. IR spectra were recorded on a
PerkinElmer Spectrum 100 FT-IR-spectrometer with only major peaks being reported. High-
resolution mass spectra (HRMS) were recorded on an LCT Premier XE benchtop orthogonal
acceleration time-of-flight (TOF) mass spectrometer (Waters Micromass).
3
Synthesis of mesylates 1a-h:
DOO
R
A
OO
O
9O
R
O
R OMS
1
RCHO (3.0 eq)
Hantzsch ester (1.0 eq)rac-proline (5 mol%)CH2Cl2, rt, 24 h
EVK (1.5 eq)Et3N (2.0 eq)EtOAcrt, 48 h
PTSA (10 mol%)Toluene, 110°C
2 h
1- NaBH4 (0.4 eq), MeOH,-40oC to -20oC, 1 h
2- MsCl (1.5 eq), Et3N (3 eq),CH2Cl2, 0°C to rt, 30 min
then
● General procedure A for the synthesis of known alkylated cyclopentanediones:
The alkylated cyclopentanediones were prepared according to a slightly modified procedure
from Ramachary:1 To a stirred solution of cyclopentanedione (1.0 eq), aldehyde (3.0 eq) and
Hantzsch ester (1.0 eq) in CH2Cl2 (0.3 M) at rt was added proline (5 mol%). The resulting
mixture was stirred for 24 h before being concentrated in vacuo. The crude reaction mixture
was then triturated with a mixture of EtOAc/Et2O (1/4). The resulting suspension was filtered,
washed with Et2O and dried in vacuo to afford the desired pure alkyl cyclopentadione.
Aa:1 According to the general procedure A, the reaction of 1,3-cyclopentanedione (200 mg,
2.0 mmol), benzaldehyde (620µL, 6.0 mmol), Hantzsch ester (517 mg, 2.0 mmol) and proline
(12 mg, 0.1 mmol) in CH2Cl2 (6.7 mL) provided Aa (310 mg, 81%) as a white powder.
1 D. B. Ramachary and M. Kishor, Org. Biomol. Chem., 2008, 6, 4176.
DOO
4
Ab:1 According to the general procedure A, the reaction of 1,3-cyclopentanedione (1.2 g,
12.20 mmol), 2-naphtaldehyde (5.73 g, 36.60 mmol), Hantzsch ester (3.1 g, 12.20 mmol) and
proline (70 mg, 0.61 mmol) in CH2Cl2 (41 mL) provided Ab (2.57 mg, 88%) as a white
powder.
Ac:2 According to the general procedure A, the reaction of 1,3-cyclopentanedione (589 mg,
6.0 mmol), anisaldehyde (2.19 mL, 18.0 mmol), Hantzsch ester (1.520 g, 6.0 mmol) and
proline (36 mg, 0.3 mmol) in CH2Cl2 (20 mL) provided Ac (1.12 g, 85%) as a white powder .
IR (film) νmax 2909, 1563, 1509, 1433, 1355, 1324, 1260, 1242, 1178, 1030, 815, 665 cm-1; 1H NMR (300 MHz, CDCl3 + 2 drops of MeOD) δ 7.08 (d, J = 8.4 Hz, 2H), 6.68 (d, J = 8.5
Hz, 2H), 3.66 (s, 3H), 3.32 (s, 2H), 2.38 (s, 4H); 13C NMR (75 MHz, CDCl3) δ 157.5, 132.2,
129.2 (2C), 117.5, 113.4 (2C), 55.0, 30.2 (2C), 25.7.
Ad:2 According to the general procedure A, the reaction of 1,3-cyclopentanedione (589 mg,
6.0 mmol), o-bromobenzaldehyde (2.10 mL, 18 mmol), Hantzsch ester (1.52 g, 6.0 mmol) and
proline (36 mg, 0.3 mmol) in CH2Cl2 (20 mL) provided Ad (1.24 g, 89%). IR (film) νmax
2922, 1568, 1383, 1267, 1035, 744, 659 cm-1; 1H NMR (300 MHz, CDCl3+ 2 drops of
MeOD) δ 7.42 (d, J = 7.7 Hz, 1H), 7.04-7.17 (m, 1H), 6.83-7.02 (m, 2H), 3.49 (s, 2H), 2.45
(s, 4H); 13C NMR (75 MHz, CDCl3) δ 197.2, 138.2, 132.2, 129.2, 127.3, 127.0, 124.4, 114.9,
30.3 (2C), 27.2.
2 K. Sudheendran, C. C. Malakar, J. Conrad, and U. Beifuss, J. Org. Chem., 2012, 77, 10194.
DOO
DOO
OMe
DOO
Br
5
Ae:1 According to the general procedure A, the reaction of 1,3-cyclopentanedione (589 mg,
6.0 mmol), o-nitrobenzaldehyde (2.72 g, 18 mmol), Hantzsch ester (1.52 g, 6.0 mmol) and
proline (36 mg, 0.3 mmol) in CH2Cl2 (20 mL) provided Ae (1.38 g, 77%). 1H NMR (300
MHz, CDCl3+ 2 drops of MeOD) δ 7.68 (d, J = 8.1 Hz, 1H), 7.30 (m, 1H), 7.06-7.19 (m, 2H),
3.63 (s, 2H), 2.36 (s, 4H); 13C NMR (75 MHz, CDCl3) δ 149.1, 134.1, 132.5, 130.7, 126.5,
124.0, 114.4, 30.0 (2C), 23.3.
Af: Triketone Af was synthesized according to known procedures.3,4,5,6
Ag:1 According to the general procedure A, the reaction of 1,3-cyclopentanedione (980 mg,
10.0 mmol), heptanaldehyde (4.20 mL, 30.0 mmol), Hantzsch ester (2.53 g, 10.0 mmol) and
proline (36 mg, 0.5 mmol) in CH2Cl2 (33 mL) provided Ag (1.37 g, 70%).
● General procedure B for the synthesis of enones:
To a stirred solution of alkylated cyclopentanedione (1.0 eq) and Et3N (2.0 eq) in
EtOAc (0.2 M) at rt was added EVK (1.5 eq). The resulting mixture was stirred for 2 days
3 P. K. Ruprah, J.-P. Cros, J. E. Pease, W. G. Whittingham and J. M. Williams, Eur. J. Org. Chem. 2002, 3145.4 E. Lacoste, E. Vaique, M. Berlande, I. Pianet, J. M. Vincent and Y. Landais, Eur. J. Org. Chem. 2007, 167.5 X.-M. Zhang, M. Wang, Y.-Q. Tu, C.-A. Fan, Y.-J. Jiang, S.-Y. Zhang and F.-M. Zhang, Synlett 2008, 2831.6 J. Xu, L. Trzoss, W. K. Chang and E. A. Theodorakis, Angew. Chem. Int. Ed. 2011, 50, 3672.
DOO
O2N
DOO
OO
6
before being concentrated in vacuo. When required, flash column chromatography of the
crude was performed to afford the triketone. Otherwise, the next step was directly carried out.
To a stirred solution of triketone (1 eq) in toluene (0.1 M) at rt was added PTSA (10% mol).
The resulting mixture was refluxed for 2 h before being cooled to rt and quenched with
NaHCO3 (sat. aq.). The resulting mixture was diluted with EtOAc, the layers were separated
and the aqueous layer was back extracted with EtOAc. The combined organic layers were
washed with brine, dried (Na2SO4) and concentrated in vacuo. Flash column chromatography
(silica gel) of the crude afforded enones 9a-i.
7
9a: According to the general procedure B, the reaction of alkylated cyclopentanedione Aa
(305 mg, 1.62 mmol), triethylamine (0.45 mL, 3.24 mmol), EVK (0.32 mL, 3.24 mmol) in
EtOAc (8.1 mL) gave triketone Ba (9.12 g, 93%) as a colorless oil (silica gel - cyclohexane:
EtOAc, 75:25). Rf = 0.35 (silica gel, cyclohexane: EtOAc, 75:25). The reaction of the
corresponding triketone (364 mg, 1.34 mmol), PTSA (26 mg, 0.13 mmol) in toluene (13.4
mL) provided enone 9a (300 mg, 88%) as colorless oil (silica gel - cyclohexane: EtOAc,
65:35). Rf = 0.45 (silica gel, cyclohexane: EtOAc, 65:35); IR (film) ν 2926, 1730, 1664,
1450, 1311, 1114, 748, 705, cm-1; 1H NMR (300 MHz, CDCl3) δ 7.22-7.31 (m, 3H), 6.98-
7.08 (m, 2H), 3.05 (d, J = 13.0 Hz, 1H), 2.98 (d, J = 13.0 Hz, 1H), 2.41-2.75 (m, 3H), 2.13-
2.40 (m, 3H), 1.97 (ddt, J = 17.7, 9.9, 1.6 Hz, 1H), 1.82 (ddd~dt, J = 13.7, 6.1 Hz, 1H), 1.81
(s, 3H); 13C NMR (75 MHz, CDCl3) δ 218.4, 197.6, 162.0, 135.7, 131.0, 129.5 (2C), 128.5
(2C), 127.3, 54.2, 42.8, 36.6, 32.6, 28.4, 25.6, 10.9; HRMS (EI): calcd for C17H18O2+ [M+]:
254.1307, found 254.1324.
9b: According to the general procedure B, the reaction of alkylated cyclopentanedione Ab
(2.57 g, 10.8 mmol), triethylamine (3.0 mL, 21.6 mmol), EVK (2.15 mL, 21.6 mmol) in
EtOAc (54 mL) provided triketone Bb (2.85 g, 82%) as colorless oil (silica gel - cyclohexane:
EtOAc, 75:25). Rf = 0.40 (silica gel, cyclohexane: EtOAc, 75:25). The reaction of the
corresponding triketone (2.85 g, 8.8 mmol), PTSA (170 mg, 0.88 mmol) in toluene (88 mL)
provided enone 9b (2.59 g, 96%) as colorless oil (silica gel - cyclohexane: EtOAc, 80:20). Rf
= 0.40 (silica gel, cyclohexane: EtOAc, 75:25); IR (film) ν 2926, 2857, 1735, 1644, 1501,
1350, 1138, 962, 825, 752, 480 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.63-7.84 (m, 3H), 7.33-
7.55 (m, 3H), 7.12 (d, J = 8.4 Hz, 1H), 3.20 (d, J = 12.9 Hz, 1H), 3.11 (d, J = 12.9 Hz, 1H),
2.42-2.76 (m, 3H), 2.07-2.29 (m, 3H), 1.71 – 1.93 (m, 2H), 1.81 (s, 3H); 13C NMR (75 MHz,
O
O
O
O
8
CDCl3) δ 218.5, 197.5, 162.1, 133.3, 133.1, 132.3, 131.0, 128.2, 128.0, 127.5 (2C), 126.3,
125.9, 54.3, 42.9, 36.6, 32.6, 28.6, 26.8, 25.7, 10.8; HRMS (EI): calcd for C21H20O2+ [M+]:
304.1463, found 304.1456.
9
9c: According to the general procedure B, the reaction of alkylated cyclopentanedione Ac
(1.12 g, 5.1 mmol), triethylamine (1.43 mL, 10.2 mmol), EVK (0.76 mL, 7.7 mmol) in EtOAc
(25.5 mL) provided triketone Bc (1.53 g, 99%) as colorless oil (silica gel chromatography -
cyclohexane: EtOAc, 75:25). Rf = 0.30 (silica gel, cyclohexane: EtOAc, 75:25). The reaction
of the corresponding triketone (261 g, 0.86 mmol), PTSA (17 mg, 0.09 mmol) in toluene (8.6
mL) provided enone 9c (244 mg, 99%) as colorless oil (silica gel - cyclohexane: EtOAc,
75:25). Rf = 0.3 (silica gel, cyclohexane: EtOAc, 75:25); IR (film) ν 2926, 2845, 1730, 1659,
1607, 1513, 1446, 1300, 1251, 1110, 1031, 964, 835, 746, 492 cm-1; 1H NMR (300 MHz,
CDCl3) δ 6.85 (d, J = 8.6 Hz, 2H), 6.69 (d, J = 8.6 Hz, 2H), 3.67 (s, 3H), 2.90 (d, J = 13.2 Hz,
1H), 2.82 (d, J = 13.2 Hz, 1H), 2.42 – 2.67 (m, 2H), 2.34 (dd, J = 18.4, 4.6 Hz, 1H), 2.12 –
2.22 (m, 2H), 1.87 – 2.11 (m, 2H), 1.71 (s, 3H), 1.68 (ddd~dt, J = 13.8, 6.0 Hz, 1H); 13C
NMR (75 MHz, CDCl3) δ 218.2, 197.3, 162.1, 158.5, 130.5, 130.3, 127.3, 113.5, 54.9, 54.0,
41.7, 36.3, 32.3, 27.9, 25.3, 10.6; HRMS (ESI): calcd for C18H21O3 [M+H]+: 285.1491, found
285.1476.
9d: According to the general procedure B, the reaction of alkylated cyclopentanedione Ad
(405 mg, 1.52 mmol), triethylamine (0.42 mL, 3.04 mmol), EVK (0.23 mL, 2.28 mmol) in
EtOAc (7.6 mL) provided triketone Bd (348 mg, 65%) as colorless oil (silica gel -
cyclohexane: EtOAc, 75:25). Rf = 0.35 (silica gel, cyclohexane: EtOAc, 75:25). The reaction
of the corresponding triketone (980 mg, 2.80 mmol), PTSA (54 mg, 0.28 mmol) in toluene
(28 mL) provided enone 9d (926 mg, 99%) as colorless oil (silica gel - cyclohexane: EtOAc,
75:25). Rf = 0.3 (silica gel, cyclohexane: EtOAc, 75:25); IR (film) ν 2921, 2848, 1738, 1662,
1653, 1439, 1348, 1115, 1024, 753, 573, 448 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.43 (d, J
= 7.9 Hz, 1H), 7.15 (t, J = 6.8 Hz, 1H), 6.97 – 7.08 (m, 2H), 3.45 (d, J = 13.3 Hz, 1H), 2.92
(d, J = 13.3 Hz, 1H), 2.51 – 2.73 (m, 2H), 2.39 (ddd, J = 18.4, 5.6, 1.5 Hz, 1H), 2.11 – 2.31
O
MeO
O
O
Br
O
10
(m, 3H), 1.85 – 2.03 (m, 1H), 1.72 (ddd~dt, J = 13.9, 5.7 Hz, 1H), 1.70 (s, 3H); 13C NMR (75
MHz, CDCl3) δ 218.0, 197.2, 160.3, 135.5, 133.0, 131.7, 131.4, 128.8, 127.3, 125.2, 53.6,
40.4, 36.8, 32.5, 28.5, 25.5, 10.8; MS (EI): 332 and 334; HRMS (EI): calcd for C17H17O2Br+
[M+]: 332.0412, found 332.0407.
9e: According to the general procedure B, the reaction of alkylated cyclopentanedione Ae
(1.24 g, 5.33 mmol), triethylamine (1.49 mL, 10.70 mmol), EVK (0.80 mL, 8.00 mmol) in
EtOAc (26.7 mL) provided triketone Be (1.45 g, 66%) as colorless oil (Silica gel
chromatography - cyclohexane: EtOAc, 65:35). Rf = 0.65 (silica gel, cyclohexane: EtOAc,
5:5). The reaction of the corresponding triketone (1.45 g, 4.60 mmol), PTSA (88 mg, 0.46
mmol) in toluene (46 mL) provided enone 9e (1.11 g, 76%) as a colorless oil (silica gel -
cyclohexane: EtOAc / 75:25). Rf = 0.55 (silica gel, cyclohexane: EtOAc, 5:5); IR (film) ν
2926, 2865, 1737, 1660, 1522, 1446, 1358, 1288, 1132, 1110, 959, 852, 786, 715, 495 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.99 (dd, J = 8.0, 1.5 Hz, 1H), 7.63 (td, J = 7.4, 1.5 Hz, 1H),
7.51 (td, J = 8.0, 1.5 Hz, 1H), 7.34 (dd, J = 7.4, 1.5 Hz, 1H), 3.93 (d, J = 13.5 Hz, 1H), 3.18
(d, J = 13.5 Hz, 1H), 2.78 – 3.01 (m, 1H), 2.26 – 2.73 (m, 5H), 2.18 (ddd, J = 13.9, 4.8, 2.3
Hz, 1H), 1.84 (s, J = 1.0 Hz, 3H), 1.68 – 1.89 (ddd~dt, J = 13.7, 6.8 Hz, 1H); 13C NMR (75
MHz, CDCl3) δ 217.2, 196.8, 160.2, 149.3, 133.2, 133.0, 131.9, 130.8, 128.6, 125.4, 52.9,
36.6 (2C), 32.3, 27.3, 25.3, 11.0; HRMS (EI): calcd for C17H17NO4+ [M+]: 299.1158, found
299.1162.
9f: To a stirred solution of 2-allylcyclopentane-1,3-dione (853mg, 6.2 mmol) and EVK (1.23
mL, 12.4 mmol) in H2O (12.4 mL) at rt was added AcOH (180 µL, 3.1 mmol). The resulting
mixture was refluxed for 4 h before being cooled down to rt and extracted with EtOAc (3 x 25
O
NO2
O
O
O
11
mL). The combined organic layers were then washed with NaHCO3 (2 x 20 mL, sat. aq.),
dried (Na2SO4) and concentrated in vacuo. Purification (silica gel, cyclohexane:EtOAc from
90:10 to 70:30) afforded triketone Bf (1.03 g, 75%) as colorless oil. Rf = 0.20 (silica gel,
cyclohexane: EtOAc, 8:2). The reaction of the corresponding triketone (810 mg, 3.6 mmol),
PTSA (69 mg, 0.36 mmol) in toluene (36 mL) provided enone 9f (661 mg, 90%) as a
colorless oil (silica gel - cyclohexane: EtOAc / 75:25). Rf = 0.25 (silica gel, cyclohexane:
EtOAc, 8:2); IR (film) ν 2949, 2921, 2870, 1739, 1649, 1436, 1354, 1316, 1160, 1113, 968,
921, 577, 491 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.55 – 5.75 (m, 1H), 4.97 – 5.14 (m, 2H),
2.25 – 2.93 (m, 8H), 2.12 (ddd, J = 13.6, 5.4, 1.8 Hz, 1H), 1.72 (s, 3H), 1.69 (ddd~dt, J =
13.9, 5.8 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 216.4, 197.6, 161.7, 131.9, 130.3, 119.2,
52.5, 39.2, 35.6, 32.1, 26.4, 24.7, 10.6; HRMS (EI): calcd for C13H16O2+ [M+]: 204.1150,
found 204.1142.
9g: According to the general procedure B, the reaction of alkylated cyclopentanedione Ag
(209 mg, 1.06 mmol), triethylamine (0.30 mL, 2.12 mmol), EVK (0.16 mL, 1.59 mmol) in
EtOAc (5.3 mL) provided triketone Bg (260 mg, 88%) as a colorless oil (silica gel –
cyclohexane: EtOAc / 65:35). Rf = 0.40 (silica gel, cyclohexane: EtOAc, 75:25). The reaction
of the corresponding triketone (260 mg, 0.93 mmol), PTSA (18 mg, 0.09 mmol) in toluene
(9.3 mL) provided enone 9g (224 mg, 92%) as a colorless oil (silica gel - cyclohexane: EtOAc
/ 75:25). Rf = 0.40 (silica gel, cyclohexane: EtOAc, 75:25); IR (film) ν 2926, 2855, 1740,
1663, 1651, 1457, 1377, 1356, 1154, 1114, 959, 573, 495 cm-1; 1H NMR (300 MHz, CDCl3)
δ 2.44 – 2.87 (m, 3H), 2.14 – 2.41 (m, 3H), 1.97 – 2.13 (m, 1H), 1.62 (s, 3H), 1.40 – 1.68 (m,
3H), 1.10 (s, 10H), 0.71 (t, J = 6.3 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 218.0, 197.2,
160.3, 135.5, 133.0, 131.7, 131.4, 128.8, 127.3, 125.2, 53.6, 40.4, 36.8, 32.5, 28.5, 25.5, 10.8;
HRMS (EI): calcd for C17H26O2+ [M+]: 262.1933, found 262.1939.
O
O
12
9h:7 According to the general procedure C, the reaction of the corresponding triketone (9.09
g, 46.4 mmol), PTSA (890 mg, 4.6 mmol) in toluene (460 mL) provided diketone 9h (8.26 g,
97%) as colorless oil (silica gel chromatography - cyclohexane: EtOAc, 60:40).
● General procedure for the synthesis of mesylates 1a-i:
To a stirred solution of diketone 9a-i (1 eq) in MeOH (0.1M) at -40oC was added
NaBH4 (0.5 eq). The resulting mixture was stirred for 1 h to -20 oC and subsequently
concentrated in vacuo. The crude was diluted with CH2Cl2 and treated with HCl (1N, aq. sol.).
The layers were separated and aqueous layer was re-extracted with CH2Cl2. The combined
organic layers were then washed with brine, dried (Na2SO4) and concentrated in vacuo
leading to the corresponding alcohol as colorless oil which was used directly without further
purification.
To a stirred solution of the crude alcohol and Et3N (3 eq) in CH2Cl2 (0.1 M) at rt was added
methanesulfonyl chloride (1.5 eq). The resulting mixture was stirred for 30 min before it was
quenched with NaHCO3 (sat. aq.). The layers were separated and the aqueous layer was re-
extracted with CH2Cl2. The combined organic layers were dried (Na2SO4) and concentrated in
vacuo. Flash column chromatography (silica gel) of the crude afforded mesylate 1a-i.
1a: According to the general procedure, the reaction of diketone 9a (294 mg, 1.16 mmol),
NaBH4 (22 mg, 0.56 mmol) in MeOH (11.6 mL) provided the crude alcohol.
The reaction of the crude alcohol, Et3N (0.49 mL, 3.48 mmol) and MsCl (0.14 mL, 1.74
mmol) in CH2Cl2 (11.6 mL) provided mesylate 1a (360 mg, 93% over two steps) as a slightly
yellow amorphous powder (silica gel – CH2Cl2: EtOAc, 95:5). Rf = 0.35 (silica gel,
7 S. G. Davies, A. J. Russell, R. L. Sheppard, A. D. Smith and J. E. Thomson, Org. Biomol. Chem. 2007, 5, 3190
O
O
O
OMs
13
cyclohexane: EtOAc, 7:3); IR (film) ν 2927, 1653, 1331, 1173, 940, 843, 703 cm-1; 1H NMR
(300 MHz, CDCl3) δ 6.97 – 7.22 (m, 5H), 4.60 (dd, J = 10.4, 8.2 Hz, 1H), 2.96 (s, 3H), 2.94
(d, J = 13.7 Hz, 1H), 2.83 (d, J = 13.7 Hz, 1H), 2.02 – 2.50 (m, 6H), 1.74 – 1.98 (m, 2H), 1.64
(s, 3H); 13C NMR (75 MHz, CDCl3) δ 196.9, 160.5, 137.1, 131.5, 130.0 (2C), 127.8 (2C),
126.5, 88.1, 48.7, 37.9, 37.5, 32.7, 32.4, 27.2, 26.1, 10.6; HRMS (EI): calcd for C18H22O4S+
[M+]: 334.1239, found 334.1226.
1b: According to the general procedure, the reaction of diketone 9b (2.5 g, 8.21 mmol),
NaBH4 (156 mg, 4.11 mmol) in MeOH (82 mL) provided the crude alcohol.
The reaction of the crude alcohol, Et3N (3.45 mL, 24.63 mmol) and MsCl (1.0 mL, 12.32
mmol) in CH2Cl2 (82 mL) provided mesylate 1b (3.0 g, 95% over two steps) as a slightly
yellow amorphous powder (silica gel– CH2Cl2: EtOAc, 95:5). Rf = 0.35 (silica gel,
cyclohexane: EtOAc, 65:35); IR (film) ν 2928, 1656, 1351, 1331, 1174, 941, 846, 754, 734
cm-1; 1H NMR (300 MHz, CDCl3) δ 7.64 – 7.80 (m, 3H), 7.56 (s, 1H), 7.35 – 7.47 (m, 2H),
7.21 (d, J = 8.4 Hz, 1H), 4.66 (dd, J = 13.7, 10.1 Hz, 1H), 3.15 (d, J = 13.7 Hz, 1H), 3.06 (d, J
= 13.7 Hz, 1H), 3.00 (s, 3H), 2.03 – 2.44 (m, 6H), 1.89 (ddd~dt, J = 12.9, 6.9 Hz, 1H), 1.72
(s, 3H), 1.63 – 1.79 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 197.3, 161.1, 135.2, 133.2, 132.2,
132.0, 129.1, 128.6, 127.7, 127.6, 127.5, 126.3, 125.8, 88.5, 49.3, 38.4, 38.0, 33.3, 32.9, 27.8,
26.6, 11.0; HRMS (ESI): calcd for C22H25O4S+ [M + H+]: 385.1474, found 385.1480.
O
OMs
14
1c: According to the general procedure, the reaction of diketone 9c (240 mg, 0.84 mmol),
NaBH4 (16 mg, 0.42 mmol) in MeOH (8.4 mL) provided the crude alcohol.
The reaction of the crude alcohol, Et3N (0.35 mL, 2.52 mmol) and MsCl (98 µL, 1.26 mmol)
in CH2Cl2 (8 mL) provided mesylate 1c (269 mg, 88% over two steps) as a light yellow
amorphous powder (silica gel – CH2Cl2: EtOAc, 9:1). Rf = 0.3 (silica gel, cyclohexane:
EtOAc, 65:35); IR (film) νmax 2921, 2854, 1652, 1512, 1330, 1245, 1172, 1018, 941, 833, 525
cm-1; 1H NMR (300 MHz, CDCl3) δ 6.96 (d, J = 8.6 Hz, 2H), 6.70 (d, J = 8.7 Hz, 2H), 4.61
(dd, J = 10.4, 8.3 Hz, 1H), 3.69 (s, 3H), 3.00 (s, 3H), 2.91 (d, J = 13.8 Hz, 1H), 2.81 (d, J =
13.8 Hz, 1H), 1.98 – 2.39 (m, 6H), 1.84 (ddd~dt, J = 13.0, 6.4 Hz, 1H), 1.68 – 1.80 (m, 1H),
1.66 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 197.1, 160.9, 158.3, 131.6, 131.0 (2C), 129.0,
113.3 (2C), 88.3, 54.9, 48.8, 38.1, 36.8, 32.9, 32.5, 27.4, 26.3, 10.7; HRMS (ESI): calcd for
C19H24O5S+ [M + H+]: 365.1423, found 365.1421.
1d: According to the general procedure, the reaction of diketone 9d (278 mg, 0.83 mmol),
NaBH4 (16 mg, 0.42 mmol) in MeOH (8.3 mL) provided the crude alcohol.
The reaction of the crude alcohol, Et3N (0.35 mL, 2.52 mmol) and MsCl (98 µL, 1.26 mmol)
in CH2Cl2 (8.3 mL) provided mesylate 1d (310 mg, 90% over two steps) as a white
amorphous powder (silica gel – CH2Cl2: EtOAc, 95:5). Rf = 0.3 (silica gel, cyclohexane:
EtOAc, 65:35); IR (film) ν 2925, 2855, 1694, 1674, 1638, 1451, 1178, 1099, 1072, 824 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.41 (d, J = 7.7 Hz, 1H), 6.90 – 7.16 (m, 3H), 4.62 (dd, J =
10.3, 8.0 Hz, 1H), 3.37 (d, J = 13.9 Hz, 1H), 3.02 (s, 3H), 2.83 (d, J = 13.9 Hz, 1H), 1.97 –
2.58 (m, 6H), 1.65 – 1.88 (m, 2H), 1.62 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 196.8, 158.8,
136.8, 133.0, 132.6, 132.3, 128.4, 126.8, 125.4, 88.1, 48.9, 38.2, 35.9, 32.4, 32.1, 27.1, 25.9,
O
OMs
MeO
O
OMs
Br
15
10.8; HRMS (ESI): calcd for C18H22O4SBr+ [M + H+]: 413.0422 and 415.0402, found
413.0418 and 415.0412.
16
1e: According to the general procedure, the reaction of diketone 9e (1.11 g, 3.7 mmol),
NaBH4 (70 mg, 1.85 mmol) in MeOH (37 mL) provided the crude alcohol.
The reaction of the crude alcohol, Et3N (1.50 mL, 11.1 mmol) and MsCl (433 µL, 5.6 mmol)
in CH2Cl2 (37 mL) provided mesylate 1e (1.25 g, 90% over two steps) as a light yellow
amorphous powder (silica gel – CH2Cl2: EtOAc / 95:5). Rf = 0.3 (silica gel, cyclohexane:
EtOAc, 6:4); IR (film) ν 3375, 2936, 1659, 1531, 1350, 1176, 940, 846, 739 cm-1; 1H NMR
(300 MHz, CDCl3) δ 7.76 (dd, J = 8.2, 1.0 Hz, 1H), 7.48 (td, J = 7.4, 1.0 Hz, 1H), 7.38 (m,
2H), 4.68 (dd, J = 10.7, 8.0 Hz, 1H), 3.55 (d, J = 14.0 Hz, 1H), 3.39 (d, J = 14.0 Hz, 1H), 3.10
(s, 3H), 2.40 (m, 3H), 2.20 – 2.29 (m, 1H), 2.16 (dd, J = 18.2, 5.6 Hz, 1H), 1.89 (m, 2H), 1.71
(dd, J = 18.6, 6.0 Hz, 1H), 1.64 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 196.6, 158.9, 150.6,
133.8, 133.4, 132.5, 131.9, 128.4, 125.1, 87.6, 48.9, 38.4, 33.2, 32.6, 32.5, 27.3, 26.1, 11.1;
HRMS (ESI): calcd for C18H22NO6S+ [M + H+]: 380.1168, found 380.1167.
1f: According to the general procedure, the reaction of diketone 9f (408 mg, 2.0 mmol),
NaBH4 (38 mg, 1.0 mmol) in MeOH (20 mL) provided the crude alcohol.
The reaction of the crude alcohol, Et3N (0.84 mL, 6.0 mmol) and MsCl (232 µL, 3.0 mmol) in
CH2Cl2 (20 mL) provided mesylate 1f (448 mg, 79% over two steps) as a white amorphous
powder (silica gel – CH2Cl2: EtOAc / 9:1). Rf = 0.4 (silica gel, cyclohexane: EtOAc, 6:4); IR
(film) ν 2933, 1655, 1352, 1331, 1174, 1015, 964, 928, 844, 757 cm-1; 1H NMR (300 MHz,
CDCl3) δ 5.71 – 5.91 (m, 1H), 4.93 – 5.11 (m, 2H), 4.60 (dd, J = 10.1, 7.9 Hz, 1H), 2.99 (s,
3H), 2.37 – 2.64 (m, 4H), 1.99 – 2.37 (m, 5H), 1.78 (ddd~dt, J = 13.6, 5.7 Hz, 1H), 1.62 (s,
3H); 13C NMR (75 MHz, CDCl3) δ 197.5, 161.8, 134.4, 130.5, 117.9, 87.9, 47.4, 38.1, 36.7,
32.5, 32.1, 27.4, 25.8, 10.6; HRMS (ESI): calcd for C14H21O4S+ [M + H+]: 285.1161, found
285.1160.
O
OMs
NO2
O
OMs
17
1g: According to the general procedure, the reaction of diketone 9g (224 mg, 0.85 mmol),
NaBH4 (16 mg, 0.43 mmol) in MeOH (8.5 mL) provided an intermediate crude alcohol.
The reaction of the crude alcohol, Et3N (0.47 mL, 3.4 mmol) and MsCl (100 µL, 1.28 mmol)
in CH2Cl2 (8.5 mL) provided mesylate 1g (266 mg, 91% over two steps) as a white
amorphous powder (silica gel – CH2Cl2: EtOAc / 95:05). Rf = 0.3 (silica gel, cyclohexane:
EtOAc, 8:2); IR (film) ν 2925, 2856, 1658, 1354, 1331, 1175, 1010, 968, 931, 845, 734 cm-1; 1H NMR (300 MHz, CDCl3) δ 4.57 (dd, J = 10.1, 7.8 Hz, 1H), 2.97 (s, 3H), 2.19 – 2.64 (m,
6H), 2.10 (m, 1H), 1.73 (ddd~dt, J = 13.1, 5.7 Hz, 1H), 1.59 (s, 3H), 1.35 – 1.51 (m, 2H), 1.17
(s, 10H), 0.78 (t, J = 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 197.6, 163.1, 129.8, 88.1,
46.9, 38.0, 32.9, 32.3, 31.8, 31.5, 30.3, 28.8, 27.6, 25.9, 25.8, 22.3, 13.8, 10.6; HRMS (ESI):
calcd for C18H31O4S+ [M + H+]: 343.1943, found 343.1944.
1h: According to the general procedure, the reaction of diketone 9h (8.03 g, 45.1 mmol),
NaBH4 (853 mg, 22.6 mmol) in MeOH (450 mL) provided the crude alcohol.
The reaction of the crude alcohol, Et3N (18.9 mL, 135.3 mmol) and MsCl (5.24 mL, 67.7
mmol) in CH2Cl2 (450 mL) provided mesylate 1h (9.15 g, 79% over two steps) as a white
amorphous powder (silica gel – CH2Cl2: EtOAc / 90:10). Rf = 0.40 (silica gel, cyclohexane:
EtOAc, 6:4); IR (film) ν 2933, 1651, 1331, 1173, 966, 890, 862 cm-1; 1H NMR (300 MHz,
CDCl3) δ 4.62 (dd, J = 10.3, 7.5 Hz, 1H), 3.05 (s, 3H), 2.27 – 2.75 (m, 5H), 2.07 – 2.23 (m,
2H), 1.87 (ddd~dt, J = 13.5, 5.7 Hz, 1H), 1.66 (s, 3H), 1.19 (s, 3H); 13C NMR (75 MHz,
CDCl3) δ 197.6, 163.0, 129.9, 87.2, 44.5, 38.3, 33.5, 32.8, 27.2, 25.3, 16.4, 10.7; HRMS
(ESI): calcd for C12H19O4S+ [M + H+]: 259.1004, found 259.1014.
O
OMs
O
OMs
18
1i: According to the general procedure, the reaction of diketone 9i (300 mg, 1.827 mmol),
NaBH4 (34.6 mg, 0.913 mmol) in MeOH (18 mL) provided the crude alcohol.
The reaction of the crude alcohol, Et3N (0.76 mL, 5.48 mmol) and MsCl (0.212 mL, 2.741
mmol) in CH2Cl2 (18 mL) provided mesylate 1i (355 mg, 80% over two steps) as a white
amorphous powder (silica gel – CH2Cl2: EtOAc / 90:10). Rf = 0.40 (silica gel, cyclohexane:
EtOAc, 6:4); IR (film) ν 2934, 1643, 1334, 1169, 1039, 962, 778, 523 cm-1; 1H NMR (300
MHz, CDCl3) δ 5.67 (s, 1H), 4.52 (dd, J = 10.1, 7.8 Hz, 1H), 2.95 (s, 3H), 2.68 (ddt, J = 19.5,
12.0, 2.5 Hz, 1H), 2.15 – 2.43 (m, 4H), 1.95 – 2.10 (m, 2H), 1.77 (ddd~dt, J = 13.5, 5.5 Hz,
1H), 1.10 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 197.6, 170.4, 123.6, 86.6, 44.4, 37.9, 33.3,
32.5, 26.5, 25.8, 15.9; MS (SCI): 244 [M]+
O
OMs
19
II) Abbreviations PTSA = p-toluenesulonic acid.
DBU = 1,8-Diazabicyclo[5.4.0]undec-7-ene.
EVK = Ethyl vinyl ketone
20
III) 1H and 13C NMR Spectra
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
4.00
1.98
5.01
2.41
3.42
7.107.127.147.167.187.19
-100102030405060708090100110120130140150160170180190200210ppm
26.48
30.06
117.01
125.43
127.85
128.08
139.87
196.88
196.93
1H NMR (300 MHz, CDCl3 & 2 drops of MeOD)
DOO
Aa
13C NMR (75 MHz, CDCl3 & 2 drops of MeOD)
21
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
4.00
2.02
2.91
3.98
2.4
3.6
7.37.37.37.37.37.37.37.47.47.67.67.77.77.77.77.77.7
-100102030405060708090100110120130140150160170180190200210ppm
26.9
30.2
117.1
124.9
125.5
126.1
127.3
127.6
131.8
133.4
137.6
208.5
1H NMR (300 MHz, CDCl3 & 2 drops of MeOD)
13C NMR (75 MHz, CDCl3 & 2 drops of MeOD)
DOO
Ab
22
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.99
2.01
3.00
2.00
1.96
2.38
3.32
3.66
6.666.70
7.067.11
-100102030405060708090100110120130140150160170180190200210220ppm
25.7
30.2
55.0
113.4
117.5
129.2
132.2
157.5
196.7
13C NMR (75 MHz, CDCl3 & 2 drops of MeOD)
1H NMR (300 MHz, CDCl3 & 2 drops of MeOD)
DOO
Ac
OMe
23
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5ppm
4.00
2.00
1.930.99
1.02
2.45
3.49
6.926.946.976.987.017.077.107.127.417.44
-100102030405060708090100110120130140150160170180190200210220ppm
27.2
30.3
114.9
124.4
127.0
127.3
129.2
132.2
138.2
197.2
13C NMR (75 MHz, CDCl3 & 2 drops of MeOD)
1H NMR (300 MHz, CDCl3 & 2 drops of MeOD)
DOO
Ad
Br
24
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
4.16
2.09
2.00
1.06
1.00
2.36
3.63
7.107.127.137.147.177.267.287.287.307.337.677.70
-100102030405060708090100110120130140150160170180190200210ppm
23.3
30.0
114.4
124.0
126.5
130.7
132.5
134.1
149.1
13C NMR (75 MHz, CDCl3 & 2 drops of MeOD)
1H NMR (300 MHz, CDCl3 & 2 drops of MeOD)
DOO
Ae
O2N
25
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
4.24
2.09
3.31
0.98
2.50
2.832.85
4.874.884.914.914.924.924.934.984.995.725.745.765.765.785.805.815.825.835.85
-100102030405060708090100110120130140150160170180190200210220ppm
25.9
31.3
114.9
116.3
136.1
13C NMR (75 MHz, MeOD)
1H NMR (300 MHz, MeOD)
DOO
Af
26
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5ppm
3.01
8.242.13
1.99
4.00
0.800.820.84
1.221.35
2.072.092.12
2.46
-100102030405060708090100110120130140150160170180190200210220ppm
14.0
20.9
22.6
28.0
29.1
29.5
30.3
31.8
118.5
13C NMR (75 MHz, CDCl3 & 2 drops of MeOD )
1H NMR (300 MHz, CDCl3 & 2 drops of MeOD )
DOO
Ag
27
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.00
3.99
3.991.91
1.98
2.00
3.00
0.880.910.93
1.821.841.881.901.911.932.282.302.332.442.48
2.83
6.916.926.936.936.947.117.127.137.13
-100102030405060708090100110120130140150160170180190200210ppm
7.4
28.3
35.6
36.0
36.2
42.7
60.9
127.0
128.3
129.5
134.9
210.1
216.8
13C NMR (75 MHz, CDCl3)
1H NMR (300 MHz, CDCl3)
OO
O
Ba
28
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.02
1.93
2.00
5.98
2.00
1.00
3.03
3.06
0.981.001.03
1.851.871.921.942.032.052.072.372.392.412.442.492.54
3.08
7.117.127.147.157.417.427.437.437.447.457.457.487.677.707.727.747.757.77
-100102030405060708090100110120130140150160170180190200210ppm
7.6
28.6
35.8
36.2
36.4
42.9
61.2
125.9
126.2
127.5
127.7
128.1
128.5
132.3
132.6
133.1
210.3
217.1
13C NMR (75 MHz, CDCl3)
1H NMR (300 MHz, CDCl3)
OO
O
Bb
29
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.05
4.04
4.04
1.96
2.02
3.05
2.00
2.01
0.910.930.96
1.881.891.901.911.941.941.962.302.322.342.46
2.81
3.69
6.676.706.866.89
-100102030405060708090100110120130140150160170180190200210ppm
7.5
28.2
35.7
36.2
36.4
42.2
55.0
61.1
113.7
126.9
130.6
158.6
210.3
217.3
13C NMR (75 MHz, CDCl3)
1H NMR (300 MHz, CDCl3)
OO
O OMe
Bc
30
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.00
2.14
5.93
2.02
1.96
1.950.99
0.99
0.810.840.86
1.881.891.901.932.202.212.222.242.332.51
2.99
6.936.936.956.977.057.057.077.087.107.107.367.397.39
-100102030405060708090100110120130140150160170180190200210ppm
7.3
27.1
35.5
35.7
36.1
40.5
59.7
125.0
127.1
128.6
131.2
132.9
134.5
210.1
214.8
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
OO
OBr
Bd
31
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.06
2.13
4.12
4.15
2.03
1.001.031.01
1.00
0.880.910.93
1.851.881.902.252.282.302.612.622.632.642.652.66
3.31
7.207.207.227.237.337.347.367.367.387.397.457.457.477.477.507.507.877.887.907.90
-100102030405060708090100110120130140150160170180190200210ppm
7.4
27.5
35.3
35.7
36.0
36.2
59.0
125.3
128.4
130.5
132.9
133.2
149.1
209.8
214.9
1H NMR (300 MHz, CDCl3)
OO
OO2N
Be
13C NMR (75 MHz, CDCl3)
32
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.11
2.07
6.21
4.23
2.06
1.00
0.900.930.95
1.811.841.862.242.272.302.312.322.342.362.522.542.552.572.592.602.652.702.722.732.762.762.79
4.975.005.035.445.465.475.495.505.515.525.525.545.555.57
-100102030405060708090100110120130140150160170180190200210ppm
7.5
26.9
35.6
35.8
36.0
39.4
59.3
120.0
131.0
210.6
215.6
13C NMR (75 MHz, CDCl3)
1H NMR (300 MHz, CDCl3)
OO
O
Bf
33
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.083.0910.35
2.06
2.00
3.97
4.01
0.650.670.690.780.810.830.920.940.961.031.081.371.421.671.691.71
2.162.182.212.232.452.482.482.532.542.562.582.592.612.642.652.652.68
-100102030405060708090100110120130140150160170180190200210ppm
7.3
13.7
22.2
24.0
26.9
28.5
29.5
31.3
34.7
35.3
35.5
35.9
59.0
210.1
215.9
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
OO
O
Bg
34
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.033.02
1.96
3.99
4.00
0.880.900.921.01
1.771.791.822.262.282.312.332.352.602.632.642.642.682.692.702.722.742.752.782.792.802.82
-100102030405060708090100110120130140150160170180190200210ppm
7.4
18.9
27.7
34.5
35.8
35.9
55.0
210.5
215.7
13C NMR (75 MHz, CDCl3)
1H NMR (300 MHz, CDCl3)
OO
O
Bh
35
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.251.07
6.17
1.97
2.00
3.09
1.811.921.931.941.951.961.971.981.991.992.012.022.022.172.172.182.192.212.222.222.232.232.242.262.292.322.352.372.432.432.452.452.492.492.512.512.552.572.602.682.702.712.732.963.003.033.07
7.027.037.047.047.257.267.277.277.277.28
-100102030405060708090100110120130140150160170180190200210ppm
10.9
25.6
28.4
32.6
36.6
42.8
54.2
127.3
128.5
129.5
131.0
135.7
162.0
197.6
218.4
13C NMR (75 MHz, CDCl3)
1H NMR (300 MHz, CDCl3)
O
9aO
36
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
4.91
3.04
3.02
1.96
1.00
2.94
2.97
1.691.711.761.801.841.872.092.112.132.142.172.192.382.402.452.462.482.492.512.522.542.552.572.602.622.63
3.003.053.093.13
7.067.087.387.397.417.437.657.687.707.727.737.75
-100102030405060708090100110120130140150160170180190200210ppm
10.6
25.4
28.1
32.3
36.2
42.5
54.0
125.7
126.0
127.3
127.3
127.7
128.0
130.7
132.0
132.9
133.1
161.8
197.2
218.1
13C NMR (75 MHz, CDCl3)
1H NMR (300 MHz, CDCl3)
O
9bO
37
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.96
2.101.941.012.02
1.97
3.00
2.00
1.96
1.661.681.711.731.751.921.982.032.032.052.072.082.092.142.152.172.192.202.362.382.442.462.482.502.552.572.802.842.882.92
3.67
6.686.716.846.87
0102030405060708090100110120130140150160170180190200210ppm
10.6
25.3
27.9
32.3
36.3
41.6
54.0
54.8
113.5
127.3
130.3
130.5
158.5
162.1
197.3
218.2
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
O
MeO
9cO
38
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
4.11
1.18
3.081.152.10
1.06
1.05
2.051.05
1.00
1.691.701.701.711.731.761.782.152.162.162.192.202.212.242.242.252.272.292.412.422.432.442.562.582.602.612.622.692.902.94
3.433.47
7.007.007.017.027.037.047.047.057.067.127.127.157.177.177.427.447.457.45
-100102030405060708090100110120130140150160170180190200210ppm
10.8
25.5
28.5
32.5
36.8
40.4
53.6
125.2
127.2
128.8
131.4
131.7
133.0
135.4
160.3
197.2
218.1
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
O
Br
9dO
39
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
4.21
1.18
5.28
1.09
1.04
1.00
1.10
2.02
1.00
1.741.771.811.841.841.872.152.162.422.462.472.502.512.532.532.552.572.603.143.21
3.903.97
7.327.337.367.367.477.477.507.517.547.557.587.597.627.637.667.677.977.978.018.01
-100102030405060708090100110120130140150160170180190200210ppm
11.0
25.3
27.3
32.3
36.6
52.9
125.3
128.6
130.8
131.9
133.0
133.2
149.3
160.2
196.8
217.2
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
O
NO2
9eO
40
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
4.11
1.07
8.36
2.04
1.00
1.641.651.681.701.721.752.092.102.112.302.312.322.352.372.382.382.412.422.442.462.482.602.612.662.672.762.802.812.83
5.025.025.055.085.095.585.605.615.615.635.645.665.665.675.695.695.705.72
-100102030405060708090100110120130140150160170180190200210ppm
10.6
24.7
26.4
32.1
35.6
39.2
52.5
119.2
130.3
131.9
161.7
197.5
216.4
13C NMR (75 MHz, CDCl3)
1H NMR (300 MHz, CDCl3)
O
O
9f
41
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.00
9.76
5.85
1.04
2.94
2.99
0.680.710.74
1.101.471.481.511.551.622.012.022.032.042.102.252.272.282.302.352.372.532.542.572.642.682.692.722.752.78
0102030405060708090100110120130140150160170180190200210ppm
10.4
13.7
22.2
24.1
24.4
25.6
28.6
29.5
31.4
32.2
34.4
35.2
52.1
129.4
162.7
197.4
216.5
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
O
9gO
42
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.12
2.881.011.03
3.00
2.92
1.281.771.771.801.821.841.861.892.032.042.052.052.072.082.092.102.342.352.362.372.412.422.432.442.452.452.462.482.492.502.512.512.542.562.572.602.622.712.712.742.752.762.762.792.812.812.822.822.832.852.852.882.882.902.912.922.922.962.96
-100102030405060708090100110120130140150160170180190200210ppm
10.7
21.1
24.4
28.7
32.7
35.3
48.8
129.7
162.4
197.8
217.5
13C NMR (75 MHz, CDCl3)
1H NMR (300 MHz, CDCl3)
O
9hO
43
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.042.20
6.33
1.044.04
1.00
1.973.00
1.721.781.781.821.901.921.962.102.112.142.162.172.222.232.242.252.292.312.322.332.342.352.362.382.40
2.902.953.003.033.043.09
4.654.684.694.72
7.097.107.117.127.197.207.207.217.227.237.24
-100102030405060708090100110120130140150160170180190200210ppm
10.9
26.4
27.6
32.7
33.1
37.8
38.3
49.0
88.4
126.8
128.1
130.3
132.0
137.3
160.8
197.4
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
1aO
OMs
44
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.63
1.23
6.25
3.091.181.05
1.00
0.992.071.023.12
1.751.871.891.911.941.961.982.112.122.142.162.202.222.242.262.292.302.322.342.372.402.412.432.442.453.033.073.123.163.20
4.674.694.704.73
7.217.227.247.247.437.447.457.467.597.697.727.747.777.787.80
-100102030405060708090100110120130140150160170180190200210ppm
10.9
26.5
27.6
32.7
33.2
37.9
38.3
49.2
88.4
125.7
126.1
127.3
127.5
127.5
128.4
128.9
132.0
132.1
133.0
135.0
161.0
197.2
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
1bO
OMs
45
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5ppm
3.082.30
6.30
1.011.073.01
3.24
1.00
2.13
2.02
1.721.771.771.811.851.891.911.941.962.142.162.172.182.202.242.242.262.272.312.322.332.332.352.382.862.902.963.003.05
3.76
4.654.684.694.72
6.746.777.007.03
-100102030405060708090100110120130140150160170180190200210ppm
10.7
26.3
27.4
32.5
32.9
36.8
38.1
48.8
54.9
88.3
113.3
129.0
131.0
131.6
158.3
160.9
197.1
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
1cO
OMs
MeO
46
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.18
1.87
6.13
1.07
2.94
1.03
1.00
3.14
1.04
1.621.661.691.751.761.821.842.002.032.102.152.192.212.232.252.272.422.462.522.552.802.873.023.343.40
4.574.614.624.66
6.956.966.986.997.027.037.067.067.077.107.107.397.43
-100102030405060708090100110120130140150160170180190200210ppm
10.8
25.9
27.1
32.1
32.4
35.9
38.2
48.9
88.1
125.4
126.8
128.4
132.3
132.6
133.0
136.8
158.7
196.8
1dO
OMs
Br
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
47
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.081.002.031.180.903.13
3.121.031.03
1.01
3.00
1.00
1.61.71.71.71.81.91.91.91.92.12.12.22.22.22.22.22.22.32.42.42.42.43.1
3.43.43.53.6
4.64.74.74.7
7.47.47.47.57.57.57.57.57.77.87.8
-100102030405060708090100110120130140150160170180190200210ppm
11.1
26.1
27.3
32.5
32.6
33.2
38.4
48.9
87.6
125.1
128.4
131.9
132.5
133.4
133.8
150.6
158.8
196.5
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
1eO
OMs
NO2
48
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5ppm
3.04
1.07
5.43
3.96
3.08
0.99
2.04
1.00
1.621.771.791.822.112.122.152.152.162.212.242.262.262.282.302.322.322.422.432.452.482.502.512.542.56
2.99
4.574.604.604.634.975.015.065.075.745.775.775.785.795.805.825.835.835.855.865.865.88
-100102030405060708090100110120130140150160170180190200210ppm
10.6
25.7
27.4
32.1
32.5
36.7
38.1
47.4
87.9
117.9
130.5
134.4
161.8
197.5
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
1fO
OMs
49
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.12
9.732.063.001.23
1.09
6.13
3.03
1.00
0.80.80.81.21.41.41.41.61.71.7
2.22.32.32.32.42.42.4
3.0
4.54.64.64.6
-100102030405060708090100110120130140150160170180190200210ppm
10.6
13.8
22.3
25.8
25.9
27.5
28.8
30.3
31.5
31.8
32.3
32.9
38.0
46.9
88.1
129.8
163.1
197.6
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
1gO
OMs
50
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.06
3.40
1.14
2.16
5.24
2.98
1.00
1.191.662.122.132.142.162.162.452.452.472.472.492.502.61
3.05
4.594.624.634.65
-100102030405060708090100110120130140150160170180190200210ppm
10.7
16.4
25.3
27.2
32.8
33.5
38.3
44.5
87.2
129.9
163.0
197.6
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
1hO
OMs
51
1H NMR (300 MHz, CDCl3)
1iO
OMs
52
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
1.17
4.28
1.13
3.15
1.00
2.07
4.76
1.781.811.851.881.911.942.042.102.132.142.172.182.202.522.522.552.552.612.622.642.652.792.802.822.852.872.882.892.912.952.96
6.156.186.886.896.906.916.927.147.157.177.177.187.197.207.247.27
-100102030405060708090100110120130140150160170180190200210ppm
9.8
29.0
33.9
43.0
47.7
127.0
128.4
130.0
134.3
134.9
135.7
150.4
162.8
196.7
200.0
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
3aO
O
53
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
1.083.021.01
1.01
2.04
0.97
0.96
1.00
1.043.02
3.09
1.881.901.921.941.961.992.172.192.212.222.232.242.272.272.292.652.652.672.672.712.712.732.962.983.003.023.033.043.073.073.093.133.17
6.226.247.077.347.367.427.447.457.467.477.48
7.737.747.767.777.787.797.81
-100102030405060708090100110120130140150160170180190200210ppm
9.8
28.9
34.0
43.1
47.9
125.9
126.3
127.5
127.6
127.9
128.0
128.7
132.2
133.1
133.2
134.3
134.9
150.4
162.8
196.7
200.0
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
3bO
O
54
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
1.132.971.10
1.06
3.04
3.18
0.96
2.012.05
1.00
1.861.891.911.931.951.972.152.172.172.192.192.212.212.232.232.652.662.672.682.852.872.882.902.912.94
3.76
6.226.24
6.766.786.796.856.88
7.297.31
-100102030405060708090100110120130140150160170180190200210ppm
9.8
28.9
33.9
42.1
47.9
55.1
113.8
127.6
131.0
134.1
134.9
150.5
158.5
162.9
196.8
200.1
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
3cO
O
MeO
55
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
1.063.131.12
1.09
0.981.12
1.04
1.00
0.991.031.05
1.001.00
2.012.022.032.052.072.102.122.282.282.302.302.322.332.342.352.622.632.642.652.692.692.712.712.942.962.983.003.023.053.073.123.363.40
6.116.136.866.876.886.897.007.017.037.037.057.067.117.127.147.147.167.177.267.447.447.467.477.487.50
-100102030405060708090100110120130140150160170180190200210ppm
9.7
30.8
33.9
41.1
48.5
125.8
127.1
128.8
132.2
133.1
134.8
135.0
135.1
149.1
161.3
196.4
199.9
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
3dO
O
Br
56
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
4.38
1.04
1.07
1.05
1.110.95
0.97
1.02
2.021.04
1.00
2.042.062.082.102.122.152.172.292.312.312.332.342.352.722.732.742.752.882.94
3.503.543.553.60
6.056.07
6.936.936.956.967.357.367.367.37
7.857.857.877.88
-100102030405060708090100110120130140150160170180190200210ppm
9.8
31.1
33.8
38.1
48.6
125.1
128.4
130.7
132.7
133.6
135.1
135.4
148.7
150.0
160.9
196.1
199.5
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
3eO
O
NO2
57
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
1.173.081.181.141.091.211.07
2.15
1.03
0.95
0.99
1.851.871.901.921.941.962.022.122.182.182.202.202.222.222.242.242.272.302.322.342.432.452.472.502.512.512.532.532.572.582.592.602.692.712.742.762.782.802.825.005.005.055.065.095.125.545.575.585.595.605.625.66
6.336.35
7.437.45
-100102030405060708090100110120130140150160170180190200210ppm
9.8
29.0
33.6
41.1
46.8
119.6
132.3
134.2
135.1
150.2
162.8
197.2
200.2
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
3fO
O
58
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.31
11.22
2.22
1.13
4.02
1.09
1.02
0.97
1.00
0.820.840.86
1.201.621.641.891.912.122.132.142.15
2.492.502.512.522.562.562.582.582.692.712.732.752.772.802.82
6.346.36
7.427.44
-100102030405060708090100110120130140150160170180190200210ppm
9.7
13.9
22.4
25.2
28.9
29.7
29.8
31.5
33.7
36.5
46.8
133.6
135.0
150.9
163.4
197.5
200.4
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
3gO
O
59
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.04
0.971.083.14
1.09
1.03
0.98
1.00
1.321.982.022.032.042.052.072.10
2.502.512.532.542.592.602.622.632.682.712.742.782.812.842.87
6.246.27
7.477.50
-100102030405060708090100110120130140150160170180190200210ppm
9.6
23.8
31.4
33.8
43.5
133.6
150.9
165.2
197.4
200.2
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
3hO
O
60
3iO
O
13C NMR (75 MHz, CDCl3)
61
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
1.263.881.281.001.041.021.09
1.071.06
4.97
1.891.901.911.931.951.961.981.981.992.002.042.042.052.062.072.102.102.112.182.212.252.282.432.442.452.462.502.502.512.522.612.632.662.672.692.722.732.842.872.912.922.943.183.233.263.293.33
7.127.137.147.157.177.197.20
-100102030405060708090100110120130140150160170180190200210ppm
10.0
33.3
33.8
39.5
45.3
50.8
52.4
124.7
125.4
127.2
127.4
136.2
140.3
145.1
151.1
200.6
208.1
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
15aO
O
H
62
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
5.741.251.151.10
2.07
1.10
1.00
1.022.162.201.00
2.112.122.152.152.172.172.202.212.222.232.242.322.352.382.412.572.572.622.632.642.642.762.782.812.822.832.84
3.153.183.203.443.50
3.833.863.89
7.377.397.467.487.497.517.517.527.537.547.557.557.577.587.737.767.787.887.897.91
-100102030405060708090100110120130140150160170180190200210ppm
10.1
33.9
34.1
40.7
44.8
49.3
52.4
123.5
123.7
125.4
126.6
128.2
128.7
130.0
133.1
136.2
137.3
140.9
151.2
200.8
208.3
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
15bO
O
H
63
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
1.364.201.36
1.081.102.08
1.091.02
1.021.051.00
2.032.042.082.092.162.172.182.282.312.342.352.372.552.602.612.622.632.732.752.782.792.922.942.972.983.003.03
3.353.413.453.483.51
7.087.107.137.207.227.267.377.40
-100102030405060708090100110120130140150160170180190200210ppm
10.1
33.6
33.7
41.1
45.4
51.3
51.7
120.5
123.6
129.2
130.7
136.8
140.9
146.9
150.4
200.4
207.5
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
15cO
O
H
Br
64
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.21
0.851.423.221.321.161.251.04
1.00
0.95
1.00
1.431.451.891.911.941.951.992.002.152.282.302.332.352.622.642.83
3.813.823.833.833.843.853.863.87
6.416.43
7.627.64
-100102030405060708090100110120130140150160170180190200210ppm
10.0
27.1
30.4
33.9
46.4
46.8
54.3
134.8
135.8
149.9
162.6
196.9
200.1
1H NMR (300 MHz, CDCl3), 1st diastereoisomer
13C NMR (75 MHz, CDCl3)
16O
O
Cl
65
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
1.275.051.18
2.31
0.99
0.93
1.00
1.491.511.941.972.132.142.172.18
2.562.602.612.632.642.672.69
3.873.883.893.903.913.923.923.933.943.953.963.98
6.406.42
7.577.59
-100102030405060708090100110120130140150160170180190200210ppm
9.9
26.5
31.0
33.7
46.3
46.7
54.0
133.8
135.6
150.5
161.5
196.7
199.8
1H NMR (300 MHz, CDCl3), 2nd diastereoisomer
13C NMR (75 MHz, CDCl3)
16'O
O
Cl
66
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0ppm
3.87
1.163.141.191.19
3.27
2.14
1.06
0.99
1.00
1.00
1.251.271.301.931.952.142.202.212.242.352.372.392.422.622.622.632.662.672.692.712.722.73
4.144.164.194.21
5.815.86
6.386.406.716.736.766.786.81
7.487.50
-100102030405060708090100110120130140150160170180190200210ppm
9.9
14.2
28.9
33.5
39.5
46.7
60.6
125.6
135.0
135.6
141.8
149.4
161.9
165.5
196.5
199.7
1H NMR (300 MHz, CDCl3)
13C NMR (75 MHz, CDCl3)
17O
O
COOEt
67